Minnesota medtech accelerator debuts, with Medtronic vet at the helm

An executive with R&D experience from Medtronic ($MDT) is co-launching Inceptis, a new medtech accelerator based in Minnesota. Daniel Sigg served as senior research manager at Medtronic a few years back and has also served in executive roles at various life sciences companies, according to his LinkedIn profile. Devicix, a product development and engineering firm, is also an equal partner in the enterprise, MedCity News reports. Inceptis will focus on Class II medical devices and plans to begin raising between $10 million and $14 million in the fall, according to the article. Story

Suggested Articles

Liquid biopsy developer Epic Sciences has brought on Myriad Genetics’ oncology chief, Lloyd Sanders, to be its new president and CEO.

Thermo Fisher Scientific has moved to acquire viral vector developer and manufacturer Brammer Bio for $1.7 billion in cash.

Bayer is teaming up with a Swedish digital health startup focused on boosting patient compliance with an internet-connected pillbox.